Solid Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	396	124	41	193	458	205	950
Market Cap Growth	-	205.62%	-79.00%	-57.88%	123.90%	-78.45%	-
Enterprise Value	304	25	-146	-15	308	128	828
PE Ratio	-1.29	-1.29	-0.47	-2.67	-5.19	-1.75	-12.69
PS Ratio	-	-	5.01	14.17	-	-	-
PB Ratio	3.19	0.98	0.19	0.93	3.47	2.56	7.59
P/FCF Ratio	-1.29	-1.29	-0.40	-2.44	-7.97	-2.11	-12.18
P/OCF Ratio	-1.32	-1.32	-0.41	-2.48	-8.10	-2.21	-13.53
EV/Sales Ratio	-	-	-18.10	-1.08	-	-	-
EV/EBITDA Ratio	-0.26	-0.26	1.75	0.21	-3.65	-1.12	-11.30
EV/EBIT Ratio	-0.26	-0.26	1.70	0.20	-3.49	-1.09	-11.07
EV/FCF Ratio	-0.26	-0.26	1.46	0.19	-5.36	-1.32	-10.62
Debt / Equity Ratio	0.21	0.21	0.13	0.01	0.04	0.09	0.01
Debt / EBITDA Ratio	-0.28	-0.28	-0.34	-0.03	-0.06	-0.06	-0.01
Debt / FCF Ratio	-0.27	-0.27	-0.28	-0.03	-0.09	-0.07	-0.01
Quick Ratio	8.64	8.64	9.58	8.90	6.33	4.59	9.84
Current Ratio	8.94	8.94	9.76	9.43	6.49	4.72	10.31
Asset Turnover	0	0	0.04	0.05	0	0	0
Return on Equity (ROE)	-62.10%	-62.10%	-48.90%	-31.30%	-140.40%	-128.80%	-48.90%
Return on Assets (ROA)	-49.00%	-49.00%	-40.00%	-28.00%	-102.80%	-104.00%	-45.50%
Return on Capital (ROIC)	-68.25%	-68.25%	-44.32%	-34.36%	-64.42%	-136.96%	-59.97%
Earnings Yield	-23.83%	-77.50%	-212.10%	-37.40%	-19.27%	-57.28%	-7.88%
FCF Yield	-23.75%	-77.24%	-247.65%	-40.95%	-12.55%	-47.45%	-8.21%
Buyback Yield / Dilution	-133.60%	-133.60%	-19.58%	-105.58%	-28.91%	-21.12%	-143.69%
Total Shareholder Return	-133.60%	-133.60%	-19.58%	-105.58%	-28.91%	-21.12%	-143.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).